D-0358-2022 Class III Terminated
FDA drug recall D-0358-2022 was initiated by Lupin Pharmaceuticals Inc. on Dec 29, 2021 and is designated Class III. Reason for recall: Out-of-specification impurity test result observed at 18-month long term stability time point. The recall status is terminated (terminated Aug 23, 2022). Affected quantity: 23,965 100 count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 12, 2022
- Initiation Date
- Dec 29, 2021
- Termination Date
- Aug 23, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 23,965 100 count bottles
Product description
Oxycodone Hydrochloride Tablets, USP C-II, 5 mg, 100 count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. NDC 43386-432-01
Reason for recall
Out-of-specification impurity test result observed at 18-month long term stability time point.
Distribution pattern
Product Distributed in NY and OH.
Code information
Lot # S000268, Exp. date January 2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0358-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026